Empyrean Diagnostics Installs Automated Production Line, Enters Joint Venture Agreements

Strategic Insights -

Empyrean Diagnostics Ltd. has made significant strides in its operations, with the installation of a new automated production line and several joint venture agreements in place. The company's production line, capable of producing 40 pouches per minute, is expected to enable the manufacturing and distribution of test kits in various regions, including Malaysia, Indonesia, Singapore, and Thailand. Additionally, Empyrean has formed joint ventures with companies in Western and Eastern Europe and the Middle East, and is in negotiations for further partnerships in China, India, and South America.

Key Takeaways:

  • Empyrean Diagnostics Ltd. has installed a new automated production line with an initial test result throughput of 40 pouches per minute.
  • The production line was designed to enable the company's joint venture partners to manufacture test kits locally.
  • Empyrean has entered into joint venture agreements with companies in Malaysia, Indonesia, Singapore, and Thailand, as well as in Western and Eastern Europe and the Middle East.
  • The joint ventures will enable the distribution of Empyrean's HIV 1,2 test kit in several regions.
  • The company is actively involved in negotiations for additional manufacturing and distribution joint ventures in China, India, and South America.

Statistics:

  • 40 pouches per minute: the rated throughput of the new automated production line.
  • Q2 1995: the possible start date for the distribution of Empyrean's test kits in Malaysia, Indonesia, Singapore, and Thailand through the Focus Profile joint venture.

Sources:

  • "Empyrean Diagnostics Ltd. Installs Automated Production Line, Enters Joint Venture Agreements," Business Wire, March 28, 1995.
  • Empyrean Diagnostics Ltd. (VSE:EMD).